Valuation Update With 7 Day Price Move • Jul 17
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥21.00, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 49x in the Aerospace & Defense industry in China. Total returns to shareholders of 14% over the past three years. Announcement • Jun 30
Wuxi Hyatech Co.,Ltd. to Report First Half, 2026 Results on Aug 18, 2026 Wuxi Hyatech Co.,Ltd. announced that they will report first half, 2026 results on Aug 18, 2026 Valuation Update With 7 Day Price Move • May 29
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to CN¥25.60, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 58x in the Aerospace & Defense industry in China. Total returns to shareholders of 41% over the past three years. Reported Earnings • Apr 17
First quarter 2026 earnings released: EPS: CN¥0.08 (vs CN¥0.12 in 1Q 2025) First quarter 2026 results: EPS: CN¥0.08 (down from CN¥0.12 in 1Q 2025). Revenue: CN¥171.5m (down 1.5% from 1Q 2025). Net income: CN¥20.0m (down 35% from 1Q 2025). Profit margin: 12% (down from 18% in 1Q 2025). Revenue is forecast to grow 33% p.a. on average during the next 2 years, compared to a 21% growth forecast for the Aerospace & Defense industry in China. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has increased by 28% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Apr 16
Wuxi Hyatech Co.,Ltd., Annual General Meeting, May 11, 2026 Wuxi Hyatech Co.,Ltd., Annual General Meeting, May 11, 2026, at 14:00 China Standard Time. Location: No. 35, Xindong'an Road, Wuxi, Jiangsu China Announcement • Mar 30
Wuxi Hyatech Co.,Ltd. to Report Q1, 2026 Results on Apr 17, 2026 Wuxi Hyatech Co.,Ltd. announced that they will report Q1, 2026 results on Apr 17, 2026 Reported Earnings • Mar 05
Full year 2025 earnings released: EPS: CN¥0.40 (vs CN¥0.49 in FY 2024) Full year 2025 results: EPS: CN¥0.40 (down from CN¥0.49 in FY 2024). Revenue: CN¥698.7m (flat on FY 2024). Net income: CN¥102.1m (down 19% from FY 2024). Profit margin: 15% (down from 18% in FY 2024). Revenue is forecast to grow 32% p.a. on average during the next 2 years, compared to a 23% growth forecast for the Aerospace & Defense industry in China. Over the last 3 years on average, earnings per share has increased by 33% per year whereas the company’s share price has increased by 30% per year. New Risk • Feb 19
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 9.8% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (9.8% average weekly change). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Valuation Update With 7 Day Price Move • Jan 09
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to CN¥31.00, the stock trades at a forward P/E ratio of 40x. Average forward P/E is 63x in the Aerospace & Defense industry in China. Total returns to shareholders of 91% over the past three years. Announcement • Dec 26
Wuxi Hyatech Co.,Ltd. to Report Fiscal Year 2025 Results on Apr 17, 2026 Wuxi Hyatech Co.,Ltd. announced that they will report fiscal year 2025 results on Apr 17, 2026 New Risk • Dec 25
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.0% average weekly change). Large one-off items impacting financial results. Reported Earnings • Oct 30
Third quarter 2025 earnings released: EPS: CN¥0.063 (vs CN¥0.099 in 3Q 2024) Third quarter 2025 results: EPS: CN¥0.063 (down from CN¥0.099 in 3Q 2024). Revenue: CN¥160.8m (down 11% from 3Q 2024). Net income: CN¥16.7m (down 35% from 3Q 2024). Profit margin: 10% (down from 14% in 3Q 2024). Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 25% growth forecast for the Aerospace & Defense industry in China. Over the last 3 years on average, earnings per share has increased by 45% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Announcement • Sep 30
Wuxi Hyatech Co.,Ltd. to Report Q3, 2025 Results on Oct 30, 2025 Wuxi Hyatech Co.,Ltd. announced that they will report Q3, 2025 results on Oct 30, 2025 Price Target Changed • Aug 16
Price target increased by 25% to CN¥29.70 Up from CN¥23.76, the current price target is provided by 1 analyst. New target price is 16% above last closing price of CN¥25.70. Stock is up 71% over the past year. The company is forecast to post earnings per share of CN¥0.67 for next year compared to CN¥0.49 last year. Reported Earnings • Aug 15
Second quarter 2025 earnings released: EPS: CN¥0.12 (vs CN¥0.14 in 2Q 2024) Second quarter 2025 results: EPS: CN¥0.12 (down from CN¥0.14 in 2Q 2024). Revenue: CN¥195.4m (up 9.1% from 2Q 2024). Net income: CN¥30.5m (down 14% from 2Q 2024). Profit margin: 16% (down from 20% in 2Q 2024). Revenue is forecast to grow 24% p.a. on average during the next 3 years, compared to a 20% growth forecast for the Aerospace & Defense industry in China. Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. Announcement • Jun 30
Wuxi Hyatech Co.,Ltd. to Report First Half, 2025 Results on Aug 12, 2025 Wuxi Hyatech Co.,Ltd. announced that they will report first half, 2025 results on Aug 12, 2025 New Risk • Jun 19
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.2% average weekly change). Large one-off items impacting financial results. Declared Dividend • Apr 27
Dividend of CN¥0.20 announced Dividend of CN¥0.20 is the same as last year. Ex-date: 6th May 2025 Payment date: 6th May 2025 Dividend yield will be 1.1%, which is higher than the industry average of 0.9%. Sustainability & Growth Dividend is well covered by both earnings (41% earnings payout ratio) and cash flows (46% cash payout ratio). The dividend has increased by an average of 26% per year over the past 3 years. However, payments have been volatile during that time. EPS is expected to grow by 113% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Valuation Update With 7 Day Price Move • Apr 08
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to CN¥15.10, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 35x in the Aerospace & Defense industry in China. Total loss to shareholders of 3.6% over the past three years. New Risk • Apr 04
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 25% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (362% cash payout ratio). Large one-off items impacting financial results. Announcement • Mar 28
Wuxi Hyatech Co.,Ltd. to Report Q1, 2025 Results on Apr 30, 2025 Wuxi Hyatech Co.,Ltd. announced that they will report Q1, 2025 results on Apr 30, 2025 Reported Earnings • Mar 28
Full year 2024 earnings: EPS and revenues exceed analyst expectations Full year 2024 results: EPS: CN¥0.49 (up from CN¥0.35 in FY 2023). Revenue: CN¥703.2m (up 29% from FY 2023). Net income: CN¥126.5m (up 40% from FY 2023). Profit margin: 18% (up from 17% in FY 2023). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.3%. Earnings per share (EPS) also surpassed analyst estimates by 1.0%. Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 26% growth forecast for the Aerospace & Defense industry in China. Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Announcement • Mar 28
Wuxi Hyatech Co.,Ltd., Annual General Meeting, Apr 17, 2025 Wuxi Hyatech Co.,Ltd., Annual General Meeting, Apr 17, 2025, at 14:00 China Standard Time. Location: Gate 1, No. 35, Xindong'an Road, Wuxi, Jiangsu China Reported Earnings • Feb 11
Full year 2024 earnings: EPS and revenues exceed analyst expectations Full year 2024 results: EPS: CN¥0.49 (up from CN¥0.35 in FY 2023). Revenue: CN¥703.2m (up 29% from FY 2023). Net income: CN¥126.6m (up 40% from FY 2023). Profit margin: 18% (up from 17% in FY 2023). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.3%. Earnings per share (EPS) also surpassed analyst estimates by 1.0%. Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 26% growth forecast for the Aerospace & Defense industry in China. Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings. Announcement • Dec 27
Wuxi Hyatech Co.,Ltd. to Report Fiscal Year 2024 Results on Mar 28, 2025 Wuxi Hyatech Co.,Ltd. announced that they will report fiscal year 2024 results on Mar 28, 2025 Reported Earnings • Oct 27
Third quarter 2024 earnings released: EPS: CN¥0.099 (vs CN¥0.14 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.099 (down from CN¥0.14 in 3Q 2023). Revenue: CN¥180.5m (up 26% from 3Q 2023). Net income: CN¥25.5m (down 28% from 3Q 2023). Profit margin: 14% (down from 25% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 22% growth forecast for the Aerospace & Defense industry in China. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Oct 15
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥15.89, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 38x in the Aerospace & Defense industry in China. Total loss to shareholders of 30% over the past three years. Announcement • Sep 30
Wuxi Hyatech Co.,Ltd. to Report Q3, 2024 Results on Oct 25, 2024 Wuxi Hyatech Co.,Ltd. announced that they will report Q3, 2024 results on Oct 25, 2024 Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment improves as stock rises 29% After last week's 29% share price gain to CN¥16.94, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 35x in the Aerospace & Defense industry in China. Total loss to shareholders of 33% over the past three years. Reported Earnings • Jul 25
Second quarter 2024 earnings released: EPS: CN¥0.14 (vs CN¥0.081 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.14 (up from CN¥0.081 in 2Q 2023). Revenue: CN¥179.0m (up 26% from 2Q 2023). Net income: CN¥35.6m (up 66% from 2Q 2023). Profit margin: 20% (up from 15% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Aerospace & Defense industry in China. Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings. Announcement • Jun 29
Wuxi Hyatech Co.,Ltd. to Report First Half, 2024 Results on Jul 25, 2024 Wuxi Hyatech Co.,Ltd. announced that they will report first half, 2024 results on Jul 25, 2024 Price Target Changed • Apr 18
Price target increased by 13% to CN¥23.85 Up from CN¥21.16, the current price target is provided by 1 analyst. New target price is 30% above last closing price of CN¥18.30. Stock is up 16% over the past year. The company is forecast to post earnings per share of CN¥0.53 for next year compared to CN¥0.35 last year. Major Estimate Revision • Apr 03
Consensus EPS estimates increase by 11% The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate increased from CN¥0.46 to CN¥0.51. Revenue forecast steady at CN¥705.8m. Net income forecast to grow 47% next year vs 42% growth forecast for Aerospace & Defense industry in China. Consensus price target up from CN¥21.16 to CN¥21.93. Share price rose 4.5% to CN¥17.24 over the past week. Announcement • Mar 29
Wuxi Hyatech Co.,Ltd. to Report Q1, 2024 Results on Apr 18, 2024 Wuxi Hyatech Co.,Ltd. announced that they will report Q1, 2024 results on Apr 18, 2024 Announcement • Mar 28
Wuxi Hyatech Co.,Ltd., Annual General Meeting, Apr 17, 2024 Wuxi Hyatech Co.,Ltd., Annual General Meeting, Apr 17, 2024, at 14:00 China Standard Time. Location: No. 35, Xindong'an Road, Wuxi, Jiangsu China Reported Earnings • Mar 28
Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind Full year 2023 results: EPS: CN¥0.35 (up from CN¥0.08 in FY 2022). Revenue: CN¥543.5m (up 50% from FY 2022). Net income: CN¥90.2m (up 350% from FY 2022). Profit margin: 17% (up from 5.5% in FY 2022). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 7.5%. Earnings per share (EPS) exceeded analyst estimates by 9.4%. Revenue is forecast to grow 34% p.a. on average during the next 2 years, compared to a 23% growth forecast for the Aerospace & Defense industry in China. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings. Major Estimate Revision • Mar 13
Consensus revenue estimates decrease by 14%, EPS upgraded The consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast fell from CN¥818.9m to CN¥701.2m. EPS estimate increased from CN¥0.44 to CN¥0.46 per share. Net income forecast to grow 33% next year vs 39% growth forecast for Aerospace & Defense industry in China. Consensus price target up from CN¥20.25 to CN¥21.16. Share price rose 17% to CN¥16.87 over the past week. Valuation Update With 7 Day Price Move • Mar 12
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to CN¥16.79, the stock trades at a forward P/E ratio of 38x. Average forward P/E is 29x in the Aerospace & Defense industry in China. Total loss to shareholders of 28% over the past three years. Reported Earnings • Feb 20
Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind Full year 2023 results: EPS: CN¥0.35 (up from CN¥0.08 in FY 2022). Revenue: CN¥543.7m (up 50% from FY 2022). Net income: CN¥90.2m (up 350% from FY 2022). Profit margin: 17% (up from 5.5% in FY 2022). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 7.5%. Earnings per share (EPS) exceeded analyst estimates by 9.4%. Revenue is forecast to grow 33% p.a. on average during the next 2 years, compared to a 24% growth forecast for the Aerospace & Defense industry in China. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 22% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Feb 01
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to CN¥12.71, the stock trades at a forward P/E ratio of 31x. Average forward P/E is 23x in the Aerospace & Defense industry in China. Total loss to shareholders of 49% over the past three years. Reported Earnings • Nov 01
Third quarter 2023 earnings released: EPS: CN¥0.14 (vs CN¥0.005 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.14 (up from CN¥0.005 in 3Q 2022). Revenue: CN¥143.7m (up 64% from 3Q 2022). Net income: CN¥35.5m (up CN¥34.2m from 3Q 2022). Profit margin: 25% (up from 1.4% in 3Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 36% p.a. on average during the next 3 years, compared to a 24% growth forecast for the Aerospace & Defense industry in China. Reported Earnings • Aug 08
Second quarter 2023 earnings released: EPS: CN¥0.081 (vs CN¥0.023 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.081 (up from CN¥0.023 in 2Q 2022). Revenue: CN¥142.4m (up 42% from 2Q 2022). Net income: CN¥21.5m (up 285% from 2Q 2022). Profit margin: 15% (up from 5.6% in 2Q 2022). The increase in margin was driven by higher revenue. Announcement • Jun 28
Wuxi Hyatech Co.,Ltd. to Report First Half, 2023 Results on Aug 08, 2023 Wuxi Hyatech Co.,Ltd. announced that they will report first half, 2023 results on Aug 08, 2023 Reported Earnings • Apr 29
First quarter 2023 earnings released: EPS: CN¥0.05 (vs CN¥0.008 in 1Q 2022) First quarter 2023 results: EPS: CN¥0.05 (up from CN¥0.008 in 1Q 2022). Revenue: CN¥113.3m (up 83% from 1Q 2022). Net income: CN¥12.5m (up CN¥10.6m from 1Q 2022). Profit margin: 11% (up from 3.1% in 1Q 2022). The increase in margin was driven by higher revenue. Reported Earnings • Mar 02
Full year 2022 earnings released: EPS: CN¥0.08 (vs CN¥0.09 in FY 2021) Full year 2022 results: EPS: CN¥0.08 (down from CN¥0.09 in FY 2021). Revenue: CN¥362.5m (up 16% from FY 2021). Net income: CN¥20.1m (down 17% from FY 2021). Profit margin: 5.5% (down from 7.8% in FY 2021). The decrease in margin was driven by higher expenses. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 6 non-independent directors. Independent Director Huiming Zhang was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 29
Third quarter 2022 earnings released: EPS: CN¥0.005 (vs CN¥0.002 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.005 (up from CN¥0.002 in 3Q 2021). Revenue: CN¥87.8m (up 10% from 3Q 2021). Net income: CN¥1.26m (up 119% from 3Q 2021). Profit margin: 1.4% (up from 0.7% in 3Q 2021). Reported Earnings • Aug 29
Second quarter 2022 earnings released: EPS: CN¥0.023 (vs CN¥0.03 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.023 (down from CN¥0.03 in 2Q 2021). Revenue: CN¥100.0m (up 37% from 2Q 2021). Net income: CN¥5.59m (down 29% from 2Q 2021). Profit margin: 5.6% (down from 11% in 2Q 2021). Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 6 non-independent directors. Independent Director Huiming Zhang was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 28
Third quarter 2021 earnings released: EPS CN¥0.002 (vs CN¥0.053 in 3Q 2020) The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: CN¥79.7m (up 21% from 3Q 2020). Net income: CN¥574.0k (down 95% from 3Q 2020). Profit margin: 0.7% (down from 16% in 3Q 2020). The decrease in margin was driven by higher expenses. Reported Earnings • Aug 30
Second quarter 2021 earnings released: EPS CN¥0.03 (vs CN¥0.053 in 2Q 2020) The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: CN¥73.0m (up 10% from 2Q 2020). Net income: CN¥7.83m (down 24% from 2Q 2020). Profit margin: 11% (down from 16% in 2Q 2020). Reported Earnings • Apr 25
First quarter 2021 earnings released: EPS CN¥0.01 (vs CN¥0.04 in 1Q 2020) The company reported a soft first quarter result with weaker earnings and profit margins, although revenues improved. First quarter 2021 results: Revenue: CN¥58.5m (up 8.9% from 1Q 2020). Net income: CN¥2.66m (down 66% from 1Q 2020). Profit margin: 4.5% (down from 14% in 1Q 2020). The decrease in margin was driven by higher expenses. Announcement • Dec 18
WUXIHYATECH Co.Ltd has completed an IPO in the amount of CNY 527.782 million. WUXIHYATECH Co.Ltd has completed an IPO in the amount of CNY 527.782 million.
Security Name: A Shares
Security Type: Common Stock
Securities Offered: 64,600,000
Price\Range: CNY 8.17
Transaction Features: Sponsor Backed Offering 
